Detection of extended-spectrum β-lactamases by using boronic acid as an AmpC β-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli

Journal of Clinical Microbiology

Volumn 45, Issue 4, 2007, Pages 1180-1184

  Song, Wonkeun ^a   Il, Kwon Bae ^b   Lee, You Nae ^b   Lee, Chae Hoon ^c   Sang, Hee Lee ^d   Seok, Hoon Jeong ^b  

^a Hallym University College of Medicine   (South Korea)

^b Kosin University College of Medicine   (South Korea)

^c Yeungnam University College of Medicine   (South Korea)

^d Myong Ji University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE AMPC; BETA LACTAMASE AMPC INHIBITOR; BORONIC ACID DERIVATIVE; CEFOTAXIME; CEFTAZIDIME; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM ISOLATION; ESCHERICHIA COLI; FALSE POSITIVE RESULT; KLEBSIELLA; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL;

BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BORONIC ACIDS; ENZYME INHIBITORS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FALSE POSITIVE REACTIONS; HUMANS; KLEBSIELLA; KLEBSIELLA INFECTIONS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

ESCHERICHIA COLI; KLEBSIELLA;

EID: 34247263339     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02322-06     Document Type: Article

References (8)

1. Beesley, T., N. Gascoyne, V. Knott-Hunziker, S. Petursson, S. G. Waley, B. Jaurin, and T. Grundstrom. 1983. The inhibition of class C beta-lactamases by boronic acids. Biochem. J. 209:229-233.
2. Bradford, P. A. 2001. Extended-spectrum p-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.
3. Brenwald, N. P., G. Jevons, J. Andrews, L. Anq, and A. P. Fraise. 2005. Disk methods for detecting AmpC β-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae. J. Antimicrob. Chemother. 56:600-601.
4. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial disk susceptibility tests, 9th ed. Approved Standard M2-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Coudron, P. E. 2005. Inhibitor-based methods for detection of plasmid-mediated AmpC β-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. J. Clin. Microbiol. 43:4163-4167.
6. Goossens, H., and B. Grabein. 2005. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004). Diagn. Microbiol. Infect. Dis. 53:257-264.
7. Ryoo, N. H., E. C. Kim, S. G. Hong, Y. J. Park, K. Lee, I. K. Bae, E. H. Song, and S. H. Jeong. 2005. Dissemination of SHV-12 and CTX-M-type extended-spectrum β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J. Antimicrob. Chemother. 56:698-702.
8. Song, W., J. S. Kim, H. S. Kim, D. Yong, S. H. Jeong, M. J. Park, and K. M. Lee. 2006. Increasing trend in the prevalence of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean universitiy hospital from 2002 to 2004. Diagn. Microbiol. Infect. Dis. 55:219-224.